Condition
Radioembolization clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Radioembolization clinical trials that are recruiting, at sites in 4 countries (most in South Korea (2), France (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Radioembolization clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Scout-dose check using resin microspheres before yttrium-90 treatment for liver tumors | — | Seoul | Recruiting | Mar 17, 2026 |
| Measuring blood flow during liver embolization procedures | — | Madison, Wisconsin | Recruiting | May 14, 2025 |
| Ablative radioembolization for localized hepatocellular carcinoma beyond the Up-To-7 criteria | Phase 2 | Gangneung, Gangwon-do and 7 other locations | Recruiting | Jan 14, 2025 |
| High-dose Y-90 radioembolization for large kidney tumors | Phase 2 | London, Ontario | Recruiting | Oct 15, 2024 |
| Characterizing liver cancer treatment with advanced imaging techniques | — | Clichy and 4 other locations | Recruiting | Mar 28, 2024 |
All recruiting trials (5)
-
Scout-dose check using resin microspheres before yttrium-90 treatment for liver tumors
This test tries a small 'scout' dose of the same resin microspheres used in yttrium-90 treatment to better measure lung shunt in adults with liver cancer or liver metastases.
-
Measuring blood flow during liver embolization procedures
This study is testing a new method to measure blood flow in patients getting liver embolization to see if it helps make treatments for liver tumors more effective.
-
Ablative radioembolization for localized hepatocellular carcinoma beyond the Up-To-7 criteria
This study is testing a new treatment using Yttrium-90 glass microspheres for people with localized liver cancer that doesn't meet certain criteria to see if it helps shrink tumors and improve survival.
-
High-dose Y-90 radioembolization for large kidney tumors
This test uses high-dose Y-90 radioembolization to try to shrink or control kidney tumors larger than 4 cm in people who cannot have surgery.
-
Characterizing liver cancer treatment with advanced imaging techniques
This study is testing new imaging techniques to see if they can help doctors better treat patients with advanced liver cancer using targeted radionuclide therapy.
Related topics
Quick answers
How many Radioembolization clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Korea (2 trials), France (1 trial), United States (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.